Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 381.55
+3.30 (0.87%)
At close: Jul 27, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 38.26 billion as of July 27, 2026. Its market cap has decreased by -1.40% in one year.
Market Cap
38.26B
Enterprise Value
41.55B
Revenue
9.44B
Ranking
n/a
PE Ratio
59.62
Stock Price
381.55
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 38.26B, an increase of 10,613.79%. That is a compound annual growth rate of 20.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 38.26B | 13.30% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 77.60B |
| FDC Limited | 67.94B |
| Bliss GVS Pharma | 48.89B |
| Novartis India | 40.23B |
| Unichem Laboratories | 38.26B |
| Morepen Laboratories | 31.01B |
| Kwality Pharmaceuticals | 28.15B |
| Hikal | 27.39B |